EP fellow @USCF | @WVUCvFellows |MDCUBB 🇹🇭| Bassett IM resident| @Arsenal | @AllBlacks | The more you know, the more you really don’t !
San Francisco, CA
Joined December 2021
- Tweets404
- Following486
- Followers240
- Likes877
Pinned Tweet
Want to share my basic ECG summary that I made for my Facebook page ECG123
Hope this helps for people who are interested in getting started on ECG reading.
drive.google.com/file/d/1fbD…
Sittinun Thangjui, MD retweeted
🆕 ACC Scientific Statement: Exercise is a foundational component of #CVD prevention & treatment. The biggest drop in CV risk happens when sedentary people become more active. Exercise prescriptions should be safe, personalized, achievable, & sustainable. bit.ly/4hxfedX
😮💨anterior and mitral line may not be as durable as we think. Need more numbers.
Durability of atrial linear lesion sets using a dual-energy lattice-tip catheter: Data from invasive remapping #OpenAccess
@MoritzNies @AndreasMetzner7
heartrhythmjournal.com/artic…
Sittinun Thangjui, MD retweeted
Preemptive left stellate ganglion block was associated with a reduced incidence of postoperative atrial fibrillation within five postoperative days in patients undergoing CABG with cardiopulmonary bypass.
Read more in #JACCCEP 👉 bit.ly/4j7PmXf #CardioX
Sittinun Thangjui, MD retweeted
So excited to be at @ACCinTouch #ACCLegCon with my #ACCFIT @MobeenMZH and boss @docsok99
One of the most important things we should be teaching tomorrows 💙 doc is the importance of #advocacy
#ACCProgramDirectors
Sittinun Thangjui, MD retweeted
Landmark clinical trials shaping contemporary guideline-directed medical therapy for heart failure see@ ow.ly/e1j750ZTnw6
@EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava
Sittinun Thangjui, MD retweeted
2026 HRS/PACES scientific statement on the use of antiarrhythmic drugs in understudied clinical scenarios
@DanielPMorin
heartrhythmjournal.com/artic…
Sittinun Thangjui, MD retweeted
CHAMPION-AF and CLOSURE-AF: reconciling contrasting results. Read this viewpoint about left atrial appendage closure #LAAC in #EHJ
👉 ow.ly/1HrK50ZFXkg
@RoccoMontone @ehj_ed
Sittinun Thangjui, MD retweeted
Among patients with ischemic or nonischemic cardiomyopathy, left ventricular ejection fraction of 36% to 50%, and myocardial scar on #CardiovascularMagneticResonance, implantation of an implantable cardioverter-defibrillator did not significantly reduce sudden cardiac death or hemodynamically significant ventricular arrhythmia vs an implantable loop recorder. Rates of all-cause mortality, cardiovascular mortality, and heart failure–related hospitalization were also similar between groups. #ESCCongress ja.ma/4gvoZHO
Sittinun Thangjui, MD retweeted
Presented at #ESCCongress:
In patients with atrial fibrillation and intermediate stroke risk, direct oral anticoagulation led to a lower risk of stroke, systemic embolism, major bleeding, or death from cardiovascular causes than no anticoagulation. Full SINGLE-AF trial results: nej.md/4ii61XB
Editorial: Anticoagulation for Atrial Fibrillation with a Single Risk Factor for Stroke nej.md/45FR7D4
@escardio
ALT A graph from the Original Article "Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk." The trial name, SINGLE-AF, is in parentheses after the title. The graph shows the cumulative incidence of primary end-point events (intention-to-treat population). The trial results are being presented at the European Society of Cardiology Congress 2026. The logo of the New England Journal of Medicine is at the bottom.
Sittinun Thangjui, MD retweeted
2026 HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS expert consensus statement update on cardiovascular implantable electronic device lead management and extraction
heartrhythmjournal.com/artic…
Sittinun Thangjui, MD retweeted
Proud to share our new study: S3 guided STaMP mapping x unstable VT(~20 sec), feasible, +safe even in high-risk patients.
jacc.org/doi/10.1016/j.jacep…
@hospitalclinic @RaimondoPi4757 @_NicolaPierucci @t_rosseel @PranavBhagirath @aportasanchez @guichard_jb
#EPeeps #VTablation
Sittinun Thangjui, MD retweeted
💬 Editorial by @gregorymmarcus, MD, MAS: Weight loss did not reduce symptoms or burden of #AtrialFibrillation in older adults with persistent disease in the LOSE-AF trial, suggesting earlier intervention may be critical.
ja.ma/4wMAnWv
Sittinun Thangjui, MD retweeted
📢 Long-term efficacy and safety of #LAAC vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomised controlled trials 👉 ow.ly/11Tw50Zu8iA
@EuropaceEiC @GiulioConteMD @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @DavideMei93 #Europace #arrhythmias #AF
🤔
Left atrial function after atrial fibrillation ablation with pulsed field vs radiofrequency energy: A comparative study
heartrhythmjournal.com/artic…
Sittinun Thangjui, MD retweeted
The paper on CSP reinforcing that LBB system is trifascicular.
Click the pic from the paper and read the correct anatomical nomenclature.
Conduction Guided Intervention: A First-in-Human Study of CTA-Guided Targeting of Proximal Conduction System Structures #OpenAccess
@OCanoPerez @HospitalLaFe
heartrhythmjournal.com/artic…
We have limited knowledge about postop non-cardiac surgery AF.
At WVU, using ICD code only 4% of 4100 truly have new AF suggested that big database is not clean.
1/4 had recurrent AF in 1 year and 0 in < 50 y. OSA and long AF predict recurrent. #epeeps
rdcu.be/fq3bp
Understanding the basic of research is important in conducting a valid research. TrinetX is a good tool with it’s limitation. We need to be mindful and use it properly.
“Medical students are using a popular research tool to pump out misleading studies” science.org/content/article/…
See what do you think about this ECG.
A Slow Regular Rhythm After TAVR: A Clinical Reasoning Exercise | Circulation ahajournals.org/doi/10.1161/…
@jkewcharoen @WvuCvFellows #Epeeps
